10.1016/j.jval.2012.08.1386

PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy

Full text

thumbnail-image

Elsevier - Publisher Connector

Provided original full text link
Last time updated on 6/5/2019

This paper was published in Elsevier - Publisher Connector .

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.